Key result
ISN/RPS 2016 classification predicts renal decline and non-remission better than the 2003 system.
Cohort (n=91)
Yes
Answers are grounded in this paper and cite their sources.
Lupus nephritis (LN) is a life-threatening complication of systemic lupus erythematosus. The 2003 pathological classification of LN was revised in 2016; it quantitatively evaluates the interstitium in addition to the glomeruli. We performed a retrospective multi-centre cohort study and investigated the utility of the 2016 classification-including the activity index (AI), chronicity index (CI), and each pathological component to predict complete remission or renal function decline, defined as 1.5-fold increase in serum creatinine levels-and compare with that of the 2003 classification. Ninety-one consecutive adult patients with first-onset class III/IV LN who were newly prescribed any immunosuppressants were enrolled and followed up for a median of 51 months from January 2004. Cox regression analysis demonstrated the subclasses based on the 2003 classification, which mainly evaluate glomerular lesions, were not associated with clinical outcomes. After adjustments for estimated glomerular filtration rate and urinary protein levels, higher CI and higher interstitial fibrosis and lower hyaline deposit scores were associated with renal functional decline. Similarly, higher CI and interstitial inflammation scores were associated with failure to achieve complete remission. Therefore, the 2016 classification can predict the clinical outcomes more precisely than the 2003 classification.
No takes yet. Share an insight, caveat, or question.
Hachiya et al. (2021) conducted a cohort in First-onset class III/IV lupus nephritis (n=91). ISN/RPS 2016 pathological classification (activity index, chronicity index, and interstitial lesions) vs. ISN/RPS 2003 pathological classification was evaluated on Complete remission or renal function decline (defined as a 1.5-fold increase in serum creatinine levels). The ISN/RPS 2016 classification (higher chronicity index and interstitial scores) predicted 1.5-fold serum creatinine increase and non-remission in 91 lupus nephritis patients unlike the 2003 system.
Synapse has enriched 10 related papers. Consider them for comparative context: